Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001 Jun 1 [cited 32202 Jan 1];120(7):1630-9 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/11375945.
Compare quality appraisals for each clinical question
- What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
- Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
- Are there groups of patients with BO that can be discharged from surveillance?
- What endoscopic surveillance protocol should be followed for patients with BO and high grade dysplasia?